Patient access to precision medicine: Identifying barriers to biomarker testing in non-small cell lung cancer.

被引：0
|
作者：
Levent, Ayse
De Richter, Pieter
Bender, Hope
机构：
[1] Ipsos, New York, NY USA
[2] Ipsos, Kuala Lumpur, Malaysia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3131
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Access to biomarker testing in patients with advanced non-small cell lung cancer.
    Borghaei, Hossein
    Hirsch, Fred R.
    Wynes, Murry
    Ravelo, Arliene
    Ramalingam, Suresh S.
    Ionescu-Ittu, Raluca
    Pivneva, Irina
    Ganti, Apar Kishor
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Biomarker Testing for Guiding Precision Medicine for Patients With Non-Small Cell Lung Cancer
    Fox, Adam H.
    Alexander, Mariam
    Forcucci, Jessica A.
    Silvestri, Gerard A.
    CHEST, 2024, 166 (05) : 1239 - 1249
  • [3] PULMONOLOGISTS' ATTITUDES AND ROLE IN PRECISION MEDICINE BIOMARKER TESTING FOR NON-SMALL CELL LUNG CANCER
    Fox, Adam
    Rudzinski, Mark
    Nietert, Paul
    Silvestri, Gerard A.
    CHEST, 2023, 164 (04) : 6503A - 6504A
  • [4] Pulmonologists' Attitudes and Role in Precision Medicine Biomarker Testing for Non-Small Cell Lung Cancer
    Fox, Adam H.
    Rudzinski, Mark A.
    Nietert, Paul J.
    Silvestri, Gerard A.
    CHEST, 2024, 166 (05) : 1229 - 1238
  • [5] Access to Biomarker Testing in Patients with Advanced Non-Small Cell Lung Cancer
    Ganti, Apar
    Hirsch, Fred R.
    Wynes, Murry
    Ravelo, Arliene
    Ramalingam, Suresh
    Ionescu-Ittu, Raluca
    Pivneva, Irina
    Borghaei, Hossein
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S964 - S965
  • [6] Precision medicine in non-small cell lung cancer KRAS - a new predictive biomarker on the horizon
    Schoellmann, Claudia
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (10) : 574 - 575
  • [7] Non-small cell lung cancer in the era of precision medicine
    Rivas, Solange
    Armisen, Ricardo
    REVISTA MEDICA CLINICA LAS CONDES, 2022, 33 (01): : 25 - 35
  • [8] Activin as a biomarker for platinum resistance in non-small cell lung cancer.
    Lim, Jennifer Wen Ying
    Murphy, Alexander David
    O'Toole, Sandra
    Nagrial, Adnan
    Karikios, Deme John
    Daneshvar, Dariush
    Murphy, Angela
    McCloy, Rachael
    Watkins, Neil
    Chin, Venessa T.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
    Sundar, Raghav
    Chenard-Poirier, Maxime
    Collins, Dearbhaile Catherine
    Yap, Timothy A.
    FRONTIERS IN MEDICINE, 2017, 4
  • [10] Non-Small Cell Lung Cancer: Recommendations for Biomarker Testing and Treatment
    Aisner, Dara L.
    Riely, Gregory J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 610 - 613
12345